| 000 | 01891 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250513123557.0 | ||
| 264 | 0 | _c19970904 | |
| 008 | 199709s 0 0 eng d | ||
| 022 | _a0277-3732 | ||
| 024 | 7 |
_a10.1097/00000421-199708000-00012 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aStewart, D J | |
| 245 | 0 | 0 |
_aMitoxantrone in the treatment of metastatic transitional cell carcinoma of the prostate. A case report. _h[electronic resource] |
| 260 |
_bAmerican journal of clinical oncology _cAug 1997 |
||
| 300 |
_a381-2 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 |
_aAntibiotics, Antineoplastic _xadministration & dosage |
| 650 | 0 | 4 |
_aAntimetabolites, Antineoplastic _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Phytogenic _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage |
| 650 | 0 | 4 |
_aBone Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aCarcinoma, Transitional Cell _xdrug therapy |
| 650 | 0 | 4 |
_aCisplatin _xadministration & dosage |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 |
_aDoxorubicin _xadministration & dosage |
| 650 | 0 | 4 | _aFatal Outcome |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethotrexate _xadministration & dosage |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMitoxantrone _xtherapeutic use |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 |
_aVinblastine _xadministration & dosage |
| 700 | 1 | _aDahrouge, S | |
| 773 | 0 |
_tAmerican journal of clinical oncology _gvol. 20 _gno. 4 _gp. 381-2 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00000421-199708000-00012 _zAvailable from publisher's website |
| 999 |
_c9236564 _d9236564 |
||